Peptinovo Biopharma

Peptinovo Biopharma

San Diego, United States· Est. 2018

We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.

Private Company

Funding information not available

About

We are currently completing pre-IND enabling testing on our first drug, PNB-281 (our PALM™ carrier with the industry-leading chemotherapy Paclitaxel). Four additional chemotherapy drugs have been developed and are ready to enter pre-IND.

Drug Delivery